Cyclophilin Inhibitors (Lead Discovery Center)

N/A

Report date: 2025/06/11 11:13:49
NME

Base Information

Drug NameCyclophilin Inhibitors (Lead Discovery Center)
Drug Alias Namecyclophilin inhibitors (Lead Discovery Center)LDC-43199LDC-45327LDC-45325
ClassificationSmall molecules
Mechanisms of ActionPeptidylprolyl isomerase inhibitors
TargetsPeptidylprolyl isomerase
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLead Discovery Center GmbH
China Registration ClassN/A

Develop Information

Active CompaniesLead Discovery Center GmbH
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A